Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04594109 · ClinicalTrials.gov registry record · NA
Development of a Tailored Smoking Cessation Program for Individuals With HIV Infection in Washington, D.C.
A NA study, sponsored by Colorado State University.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT04594109 is a NA study that has completed, run by Colorado State University. The registered enrollment target is 25 participants.
The verdict
NCT04594109, a NA study, has completed, sponsored by Colorado State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Morbidity and mortality from smoking-related diseases among people living with HIV (PLWH) in the U.S. surpasses that due to HIV itself. Conventional smoking cessation treatments have not demonstrated strong efficacy among PLWH. The investigators conducted a pilot randomized controlled trial (RCT) to evaluate a tailored smoking cessation intervention based on the minority stress model, hypothesizing that behavioral counseling through this lens would enhance cessation. The investigators compared standard of care counseling (SOC) to a tailored intervention (TI) including one face-to-face counseling session incorporating cognitive behavioral therapy to build resilience, and 30 days of 2-way text messaging.
Interventions
- BEHAVIORAL Standard of Care
- BEHAVIORAL Tailored behavioral counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-06-30 |
| Est. Completion | 2018-01-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04594109
The ClinicalTrials.gov registry entry for NCT04594109 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Colorado State University, which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT04594109 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04594109 about?
NCT04594109 is a clinical study titled "Development of a Tailored Smoking Cessation Program for Individuals With HIV Infection in Washington, D.C.". Morbidity and mortality from smoking-related diseases among people living with HIV (PLWH) in the U.S. surpasses that due to HIV itself. Conventional smoking cessation treatments have not demonstrated strong efficacy among PLWH. The investigators conducted a pilot randomized controlled trial (RCT) to...
What is the current status of trial NCT04594109?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2017-06-30. Estimated completion is 2018-01-30.
What interventions are being tested in trial NCT04594109?
The interventions under investigation include: Standard of Care (BEHAVIORAL), Tailored behavioral counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT04594109?
This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.